Can a glucometer with an intelligent mobile application become an alternative to continuous glycemic monitoring?

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Objective. Substantiation of the use of intelligent mobile applications for glucometers for more effective remote management of diabetes mellitus (DM) as a real alternative to continuous glycemic monitoring (CGM) for diabetic patients with DM.

Key provisions. Achieving adequate control of DM is impossible without self-monitoring by the patient. Guidelines for managing patients with DM are regularly updated, more modern approaches to self-monitoring of glycemia are developed, innovative glucometers, systems with a mobile application, are introduced. Continuous glucose monitoring systems are increasingly used. The use of CGM and FMG technologies allows for real-time glycemia control. Meta-analyses of studies evaluating the effectiveness of these technologies show advantages in increasing the percentage of time glycemia is in the target range and reducing periods of hypoglycemia, and the use of a food diary in the form of an application contributes to more effective weight loss. The use of modern mobile applications to a glucometer or CGM allows for increasing patient motivation and expanding opportunities for disease management.

Texto integral

Acesso é fechado

Sobre autores

Olga Koteshkova

Endocrinology Dispensary of the Moscow Healthcare Department

Autor responsável pela correspondência
Email: koala58@mail.ru
ORCID ID: 0000-0001-8428-4116
Código SPIN: 6141-1224

Cand. Sci. (Med.), Head of the Department of Diabetes Education and Treatment

Rússia, Moscow

Darya Antsiferova

Endocrinology Dispensary of the Moscow Healthcare Department; Russian Medical Academy of Continuous Professional Education

Email: cifrenda@yandex.ru
ORCID ID: 0000-0002-3920-5914

Postgraduate Student, Department of Endocrinology, Endocrinologist

Rússia, Moscow; Moscow

Mikhail Antsiferov

Endocrinology Dispensary of the Moscow Healthcare Department; Russian Medical Academy of Continuous Professional Education

Email: antsiferov@rambler.ru
ORCID ID: 0000-0002-9944-2997
Código SPIN: 1035-4773

Dr. Sci. (Med.), Professor, Chief Physician

Rússia, Moscow; Moscow

Bibliografia

  1. URL: www. diabetesatlas.org. Facts & figures (idf.org) https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html.
  2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986. doi: 10.1056/NEJM199309303291401.
  3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853. doi: 10.1016/S0140-6736(98)07019-6.
  4. Дедов И.И., Шестакова М.В., Майоров А.Ю. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 11-е изд. М., 2023. doi: 10.14341/DM13042. [Dedov I.I., Shestakova M.V., Mayorov A.Yu. Algorithms of specialized medical care for patients with diabetes mellitus. 11th ed. M., 2023. (In Russ.)]. doi: 10.14341/DM13042.
  5. Nathan D.M., Cleary P.A., Backlund J.-Y.C., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–2653. doi: 10.1056/NEJMoa052187
  6. ADVANCE Collaborative Group, Patel A., MacMahon S., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–2572. doi: 10.1056/NEJMoa0802987.
  7. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–139. doi: 10.1056/NEJMoa0808431
  8. ACCORD Study Group, Gerstein H.C., Miller M.E., et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364:818–828. doi: 10.1056/NEJMoa1006524.
  9. Akturk H.K., Dowd R., Shankar K., et al. Real-world evidence and glycemic improvement using Dexcom G6 features. Diabetes Technol Ther. 2021;23:21–26. doi: 10.1089/Dia.2020.0654.
  10. Gomez-Peralta F., Dunn T., Landuyt K. et al. Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain. BMJ Open Diabetes Res Care. 2020;8(1):e001052. doi: 10.1136/bmjdrc-2019-001052.
  11. Willis H.J., Asche S.E., McKenzie A.L. et al. Impact of continuous glucose monitoring versus blood glucose monitoring to support a carbohydrate-restricted nutrition intervention in people with type 2 diabetes. Diabetes Technol Ther. 2024 Nov 11. doi: 10.1089/dia.2024.0406.
  12. Martens T.W., Willis H.J., Bergenstal R.M., et al. A randomized controlled trial using continuous glucose monitoring to guide food choices and diabetes self-care in people with type 2 diabetes not taking insulin. Diabetes Technol Ther. 2025;27:261–270. doi: 10.1089/dia.2024.0579.
  13. Martens T., Beck R.W., Bailey R,, et al. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin. A randomized clinical trial. JAMA 2021;325:2262–2272. doi: 10.1001/jama.2021.7444.
  14. Fisher L., Fortmann A., Stuhr A. Can a basic management app paired with a glucose meter help reduce glucose levels among adults with type 2 diabetes? The REALL Study. J Diabetes Sci Technol. 2024;18(1):99–105. doi: 10.1177/19322968221096163.
  15. Steinhubl S.R., Muse E.D, Topol E.J. Can mobile health technologies transform health care? JAMA. 2013;310(22):2395–2396. doi: 10.1001/jama.2013.281078.
  16. Hansen A.H., Wangberg S.C., Arsand E. Lifestyle changes among people with type 2 diabetes are associated with participation in online groups and time since diagnosis. BMC Health Serv Res. 2021;21(1):688. doi: 10.1186/s12913-021-06660-5.
  17. Wu I.X.Y., Kee J.C.Y., Threapleton D.E., et al. Effectiveness of smartphone technologies on glycaemic control in patients with type 2 diabetes: systematic review with meta-analysis of 17 trials. Obes Rev. 2018;9(6):825–38. doi: 10.1111/obr.12669.
  18. Tchero H., Kangambega P., Briatte C., et al. Clinical effectiveness of telemedicine in diabetes mellitus: a meta-analysis of 42 randomized controlled trials. Telemed J E Health. 2019;25(7):569–583. doi: 10.1089/tmj.2018.0128.
  19. Haider R., Sudini L., Chow C.K., Cheung N.W. Mobile phone text messaging in improving glycaemic control for patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2019;150:27–37. doi: 10.1016/j.diabres.2019.02.022.
  20. Middleton T., Constantino M., McGill M., et al. An enhanced SMS text message-based support and reminder program for young adults with type 2 diabetes (TEXT2U): randomized controlled trial. J Med Internet Res. 2021;23(10):e27263. doi: 10.2196/27263.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar
2. Figure 1. Visualization of food portions on the smartphone screen

Baixar (90KB)
Metadados
3. Figure 2. Report form of the mobile application Contour Diabetes

Baixar (373KB)
Metadados
4. Figure3. Glycemic monitoring data using the Contour Diabetes application

Baixar (311KB)
Metadados

Declaração de direitos autorais © Bionika Media, 2025